Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
CASH FLOW FROM OPERATING ACTIVITIES:
Net loss	$ (70,105)	$ (106,869)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	10,691	9,115
Amortization of deferred contract acquisition costs	15,284	10,740
Non-cash operating lease costs	957	943
Stock-based compensation expense	58,553	55,549
Accretion of discounts, and amortization of premiums on investments, net	(3,628)	(5,167)
Other	1,551	939
Accounts receivable	80,911	23,583
Prepaid expenses and other assets	3,904	3,237
Deferred contract acquisition costs	(15,207)	(12,091)
Accounts payable	2,368	1,127
Accrued liabilities	(2,515)	1,392
Accrued payroll and benefits	(18,897)	(10,917)
Operating lease liabilities	(1,481)	(1,110)
Deferred revenue	(22,108)	2,237
Other liabilities	1,725	(767)
Net cash provided by (used in) operating activities	42,003	(28,059)
CASH FLOW FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(886)	(462)
Purchases of intangible assets	(73)	(173)
Capitalization of internal-use software	(7,361)	(2,912)
Purchases of investments	(246,965)	(150,639)
Sales and maturities of investments	210,574	185,296
Cash paid for acquisition, net of cash acquired	(61,553)	0
Net cash (used in) provided by investing activities	(106,264)	31,110
CASH FLOW FROM FINANCING ACTIVITIES:
Repurchase of common stock	(21)	0
Proceeds from exercise of stock options	6,554	9,762
Net cash provided by financing activities	6,533	9,762
NET CHANGE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	(57,728)	12,813
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH–Beginning of period	322,086	202,406
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH–End of period	264,358	215,219
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Income taxes paid, net of refunds	1,492	148
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock-based compensation capitalized as internal-use software	4,078	1,224
Property and equipment purchased but not yet paid	147	0
Vesting of early exercised stock options	$ 0	$ 49